Mice with diverse microbial exposure histories as a model for preclinical vaccine testing

Jessica K Fiege1, Katharine E Block2, Mark J Pierson2

  • 1Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455, USA; Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA.

Cell Host & Microbe
|November 3, 2021
PubMed

Insights

Introducing diverse microbes to lab mice via co-housing improves preclinical vaccine modeling. This approach better mimics human immune responses to influenza vaccines, enhancing their predictive value for human immunity.

Area of Science:

  • Immunology
  • Microbiome research
  • Vaccinology

Background:

  • Laboratory mice are crucial for preclinical vaccine testing.
  • Current models often fail to accurately predict human immune responses.
  • Specific pathogen-free (SPF) mice lack diverse microbial exposure, limiting their translational relevance.

Purpose of the Study:

  • To investigate if diverse microbial exposure in mice enhances the modeling of human immune responses to influenza vaccines.
  • To compare the immunogenicity and protective efficacy of influenza vaccines in mice with standard SPF conditions versus those with diverse microbial experience.

Main Methods:

  • Co-housing of specific pathogen-free (SPF) laboratory mice with pet-store mice to introduce diverse microbial exposures.
  • Assessment of immune responses, including transcriptional profiles, to influenza vaccination.
  • Evaluation of vaccine-induced protection against influenza challenge, including humoral and T-cell mediated immunity.

Main Results:

  • Co-housed mice better recapitulated human transcriptional responses to influenza vaccination.
  • While susceptibility to acute infection was similar, vaccine-induced humoral responses were reduced in co-housed mice.
  • Protective heterosubtypic T-cell immunity was compromised in co-housed mice compared to SPF mice.

Conclusions:

  • Reconstituting diverse microbial experience in laboratory mice through co-housing may improve preclinical vaccine testing.
  • This approach offers a more physiologically relevant model for predicting human vaccine efficacy.
  • Further research is needed to optimize microbial reconstitution strategies for enhanced vaccine immunogenicity prediction.